FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Genentech Klonopin Recall

Klonopin (clonazepam) 0

Genentech, Inc. · South San Francisco, CA

Risk level
Class III
Reported by FDA
Feb 21, 2018
Recall ID
D-0416-2018
Check your lot numberHow we source this data

Summary

Genentech recalled Klonopin starting Feb 5, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0416-2018 on Feb 21, 2018. Reason: Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.

Product description

Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01

Lot numbers, UPCs & expiration codes

Lot # 3141989, EXP 08/31/2019

Where it was sold

Distributed throughout the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0416-2018
Classification
Class III
Status
Terminated
Recall initiated
Feb 5, 2018
FDA report date
Feb 21, 2018
Quantity
3,192 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Genentech, Inc.

Original FDA data

Every field from FDA enforcement report D-0416-2018, exactly as published.

Show all FDA fields
City
South San Francisco
State
CA
Status
Terminated
Country
United States
Event ID
79175
Address
1 Dna Way
Code information
Lot # 3141989, EXP 08/31/2019
Postal code
94080-4990
Report date
Feb 21, 2018
Product type
Drugs
Recall number
D-0416-2018
Classification
Class III
Recalling firm
Genentech, Inc.
Product quantity
3,192 bottles
Termination date
Sep 6, 2018
Reason for recall
Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genentech USA, Inc. A Member of the Roach Group, 1 DNA Way South San Francisco, CA 94080-4990. NDC 0004-0068-01
Distribution pattern
Distributed throughout the United States
Recall initiation date
Feb 5, 2018
Initial firm notification
Letter
Center classification date
Feb 13, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0416-2018, published Feb 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls